Home › Calculator › ERAS Dividend Calculator 2026
ERAS Dividend Calculator 2026
No dividendHealthcareErasca, Inc. · NASDAQ
Price: $15.12 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
ERAS is not a dividend-focused stock
ERAS pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
ERAS Dividend Yield
Erasca, Inc. (ERAS) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When ERAS pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About Erasca, Inc. (ERAS) — Dividend Analysis 2026
Erasca, Inc. is a biopharmaceutical company in the clinical development stage, primarily focused on identifying, advancing, and commercializing therapeutic solutions for malignancies propelled by the RAS/MAPK pathway. The firm's pipeline features several key experimental drugs: ERAS-007, an orally administered ERK1/2 inhibitor designed to address non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; and ERAS-601, an oral SHP2 inhibitor targeting patients with advanced or metastatic solid tumors. Additionally, Erasca is progressing ERAS-801, an EGFR inhibitor capable of penetrating the central nervous system, intended for recurrent glioblastoma multiforme. The company was founded in 2018 and maintains its headquarters in San Diego, California.
ERAS Dividend & DRIP — Frequently Asked Questions
Does ERAS pay a dividend?
No. Erasca, Inc. (ERAS) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of ERAS?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does ERAS have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. ERAS has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to ERAS
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full ERAS DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open ERAS position with:
🌍 ERAS Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold ERAS.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 ERAS Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 ERAS Dividend Payment Schedule
ERAS pays quarterly — 4 times per year. Ex-div: —.
📊 ERAS vs Healthcare Benchmarks
How ERAS compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ERAS sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ ERAS Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-08-10 | 1,300,000 | $18.12 | $23.56M | ||
| A-Award | 2026-06-26 | 29,888 | $16.01 | $478.5K | ||
| A-Award | 2026-06-26 | 29,888 | $16.01 | $478.5K | ||
| A-Award | 2026-06-26 | 29,888 | $16.01 | $478.5K | ||
| A-Award | 2026-06-26 | 29,888 | $16.01 | $478.5K | ||
| A-Award | 2026-06-26 | 29,888 | $16.01 | $478.5K | ||
| A-Award | 2026-06-26 | 29,888 | $16.01 | $478.5K | ||
| M-Exempt | 2026-04-01 | 80,000 | $1.70 | $136.0K | ||
| M-Exempt | 2026-04-01 | 80,000 | $1.70 | $136.0K | ||
| Sale | 2026-04-01 | 80,000 | $16.40 | $1.31M |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Peer Group
Similar companies in the same sectorCompare ERAS with peers: ERAS vs ARVN · ERAS vs ATXS · ERAS vs AVBP
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ERAS dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Erasca, Inc. (ERAS) is currently trading at $15.12, 38% below its 52-week high. It does not currently pay a regular dividend.
Does ERAS Pay a Dividend? Erasca, Inc. Dividend Status
Erasca, Inc. (ERAS) is a healthcare stock trading at $15.12. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest ERAS News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.
Projected your ERAS DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.